PPM1H and neoplasm: Upon multivariate analysis, patients with PPM1H-low tumour had a higher risk of CRC relapse compared with patients with PPM1H-high tumours (HR, 1.370; 95% CI, 1.032 to 1.818; P = 0.029) (Table 2).